As an ALSA Certified Center of Excellence for the treatment of ALS, we are committed to participating in research studies to improve our understanding of the disease and work towards new treatments. We are currently involved in the following studies:
Healey ALS Platform Trial | IRB# 2019-760
The purpose of this perpetual multi-center, multi-regimen, inpatient/outpatient trial is to evaluate the safety and efficacy of investigational products for the treatment of ALS.
Clinical Investigator: Paul Twydell, DO